Td Asset Management Inc Acadia Pharmaceuticals Inc Transaction History

Td Asset Management Inc

$114 Billion
Q3 2025

A detailed history of Td Asset Management Inc transactions in Acadia Pharmaceuticals Inc stock. As of the latest transaction made, Td Asset Management Inc holds 65,000 shares of ACAD stock, worth $1.56 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

65,000

Previous 45,000 44.44%

Holding current value

$1.56 Million

Previous $970,000 42.99%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 10, 2025	BUY	$20.88 - $26.57 $417,600 - $531,400	20,000 Added 44.44%	65,000 $1.39 Million
Q2 2025 Jul 28, 2025	BUY	$14.1 - $22.95 $634,500 - $1.03 Million	45,000 New	45,000 $970,000
Q2 2024 Aug 02, 2024	SELL	$14.62 - $18.42 $1.21 Million - $1.53 Million	-82,800 Reduced 78.04%	23,296 $378,000
Q1 2024 May 08, 2024	SELL	$17.79 - $30.86 $1.79 Million - $3.1 Million	-100,400 Reduced 48.62%	106,096 $1.96 Million
Q4 2023 Feb 12, 2024	SELL	$20.78 - $31.77 $398,976 - $609,984	-19,200 Reduced 8.51%	206,496 $6.47 Million

Q3 2023 Oct 27, 2023	BUY	$20.84 - $33.47 $1.07 Million - $1.72 Million	51,273 Added 29.4%	225,696 $4.7 Million
Q2 2023 Aug 09, 2023	BUY	$17.8 - $25.65 $1.02 Million - $1.47 Million	57,502 Added 49.18%	174,423 $4.18 Million
Q1 2023 May 10, 2023	BUY	$16.32 - $20.92 $221,952 - $284,512	13,600 Added 13.16%	116,921 $2.2 Million
Q4 2022 Feb 06, 2023	SELL	$14.2 - $18.63 $331,413 - $434,805	-23,339 Reduced 18.43%	103,321 $1.64 Million
Q3 2022 Nov 07, 2022	BUY	$14.11 - $18.27 $215,883 - $279,531	15,300 Added 13.74%	126,660 $2.04 Million
Q2 2022 Aug 04, 2022	BUY	$13.01 - $27.22 $200,354 - $419,188	15,400 Added 16.05%	111,360 $1.57 Million
Q1 2022 May 10, 2022	SELL	$20.94 - $27.5 $856,069 - $1.12 Million	-40,882 Reduced 29.88%	95,960 $2.32 Million
Q4 2021 Feb 10, 2022	BUY	$16.79 - $27.09 $197,970 - $319,418	11,791 Added 9.43%	136,842 $3.19 Million
Q3 2021 Nov 09, 2021	SELL	$15.78 - $24.77 $200,406 - $314,579	-12,700 Reduced 9.22%	125,051 $2.08 Million
Q2 2021 Aug 11, 2021	SELL	$19.4 - $27.42 $34,260 - $48,423	-1,766 Reduced 1.27%	137,751 $2.98 Million
Q1 2021 May 14, 2021	SELL	$25.02 - $54.99 $1.09 Million - $2.4 Million	-43,656 Reduced 23.83%	139,517 $3.6 Million
Q4 2020 Feb 16, 2021	SELL	$41.04 - $56.79 $2.43 Million - $3.36 Million	-59,200 Reduced 24.43%	183,173 $9.79 Million
Q3 2020 Nov 10, 2020	SELL	$36.42 - $57.0 $477,102 - $746,700	-13,100 Reduced 5.13%	242,373 $10 Million
Q2 2020 Aug 13, 2020	BUY	$39.26 - $52.73 $404,260 - $542,960	10,297 Added 4.2%	255,473 $12.4 Million
Q1 2020 May 15, 2020	SELL	$31.65 - $46.87 $1.2 Million - $1.78 Million	-37,943 Reduced 13.4%	245,176 $10.4 Million
Q4 2019 Feb 11, 2020	BUY	$36.21 - $51.4 $2.72 Million - $3.87 Million	75,214 Added 36.18%	283,119 $12.1 Million
Q3 2019 Nov 07, 2019	BUY	$22.22 - $44.01 $943,372 - $1.87 Million	42,456 Added 25.66%	207,905 $7.48 Million
Q2 2019 Aug 01, 2019	BUY	$23.32 - $28.12 $132,924 - $160,284	5,700 Added 3.57%	165,449 $4.42 Million
Q1 2019 May 08, 2019	BUY	$16.17 - $27.38 $202,125 - $342,250	12,500 Added 8.49%	159,749 $4.29 Million
Q4 2018 Feb 01, 2019	BUY	$14.32 - $22.92 $567,773 - $908,755	39,649 Added 36.85%	147,249 $2.38 Million
Q3 2018 Nov 01, 2018	BUY	$13.03 - $21.81 $1.4 Million - $2.35 Million	107,600 New	107,600 $2.23 Million
Q4 2017 Feb 02, 2018	SELL	$26.84 - $39.14 $879,305 - $1.28 Million	-32,761 Closed	0 $0
Q3 2017 Nov 09, 2017	BUY	$29.49 - $38.37 $966,121 - $1.26 Million	32,761	32,761 $1.23 Million

Others Institutions Holding ACAD

# of Institutions

373

Shares Held

162M

Call Options Held

1.46M

Put Options Held

1.09M

View Full List

About ACADIA PHARMACEUTICALS INC

Ticker ACAD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 161,843,008
Market Cap $3.89B
Description
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's p...

More about ACAD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Td Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Td Asset Management Inc with notifications on news.

Account

Td Asset Management Inc Acadia Pharmaceuticals Inc Transaction History